Average Co-Inventor Count = 3.74
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (22 from 4,442 patents)
2. Princeton University (13 from 1,079 patents)
3. National Health Research Institutes (8 from 181 patents)
4. Other (1 from 832,680 patents)
5. University of Minnesota (1 from 2,304 patents)
6. Academia Sinica (1 from 685 patents)
38 patents:
1. 11878986 - Poly heterocyclic conjugates and their pharmaceutical uses
2. 11623951 - Antibodies to R-spondin 3
3. 11084873 - Anti-Abeta antibodies and uses thereof
4. 10882854 - Heterocyclic compounds and use thereof
5. 10597378 - Tetrahydroisoquinolines for use as MOR/NOP dual agonists
6. 10584120 - Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease
7. 10544113 - Thiazolidinone compounds and use thereof
8. 10300061 - Aminothiazole compounds as protein kinase inhibitors
9. RE43878 - Amidophenoxyindazoles useful as inhibitors of c-Met
10. 8030302 - Amidophenoxyindazoles useful as inhibitors of c-Met
11. 7767674 - Kinase inhibitors
12. 7652015 - Kinase inhibitors
13. 7582652 - Kinase inhibitors
14. 7582638 - Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
15. 7547691 - [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases